Hospital
Madison County Hospital Health Systems, INC.
Madison County Hospital Health Systems, INC. was paid $2.06M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoMADISON COUNTY HOSPITAL HEALTH SYSTEMS, INC.
MADISON, FL 32340
MADISON, FL 32340
33aNPI1104821461assigned 06/14/2005
33bProvider typeCritical Access Hospital
28Total paid$2.06M
24GClaims63,332
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Florida
Rank by total paid#9 of 12
Median peer was paid$3.14M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,756 | $32K | |
| 2019 | 12,706 | $221K | |
| 2020 | 10,176 | $204K | |
| 2021 | 13,770 | $376K | |
| 2022 | 12,222 | $553K | |
| 2023 | 8,183 | $384K | |
| 2024incomplete | 4,519 | $294K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 8,762 | 7,945 | $754K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 5,136 | 4,752 | $500K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10.0% | 2,174 | 2,047 | $206K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5.1% | 2,038 | 1,612 | $105K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 1,277 | 1,001 | $67K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.9% | 4,925 | 2,670 | $60K |
| 36415 | Collection of venous blood by venipuncture | 2.8% | 3,869 | 3,177 | $57K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 399 | 323 | $34K |
| 80053 | Comprehensive metabolic panel | 1.6% | 4,526 | 3,853 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 5,034 | 4,241 | $30K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 4,895 | 3,748 | $26K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 672 | 575 | $24K |
40 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 1,758 | $23K |
| 81001 | <1% | 2,594 | $18K | |
| 84484 | <1% | 1,634 | $17K | |
| 82553 | <1% | 1,716 | $16K | |
| 82550 | <1% | 1,769 | $16K | |
| 87430 | <1% | 1,488 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 151 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 722 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,818 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 793 | $6K |
| 83880 | <1% | 183 | $5K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 485 | $4K |
| 83735 | <1% | 437 | $4K | |
| 80305 | <1% | 307 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 331 | $3K |
| 85610 | <1% | 191 | $3K | |
| 85730 | <1% | 116 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 398 | $2K |
| 83690 | <1% | 155 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 23 | $1K |
| 81025 | <1% | 1,278 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 43 | $880.15 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 647 | $836.83 |
| 73130 | <1% | 88 | $713.37 | |
| 73630 | <1% | 13 | $649.70 | |
| 85378 | <1% | 15 | $643.27 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 33 | $633.55 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 53 | $478.16 |
| 73030 | <1% | 15 | $471.87 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 13 | $465.01 |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 26 | $277.30 |
| 83605 | <1% | 15 | $203.60 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 29 | $170.59 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 18 | $104.20 |
| 73564 | <1% | 18 | $47.45 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 50 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 52 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 112 | $0.00 |
| 85007 | 0% | 26 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTEVENS, TAMMY (C.E.O.)